{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:05:11Z","timestamp":1793192711188,"version":"4.5.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish government funds for clinical research"},{"name":"Region Sk\u00e5ne clinical research grants"},{"name":"The Swedish Heart and Lund Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Lung injury in COVID-19 is characterized by neutrophil invasion and the release of neutrophil extracellular traps (NETs). An aberrant NET formation may induce local inflammation and increase sputum viscosity. Inhalation of DNase I (dornase alfa) is a treatment option that degrades NETs in the airways. Previous case series have indicated positive clinical effects of inhaled dornase alfa.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients admitted to the hospital with acute COVID-19 and hypoxia (oxygen saturation &amp;lt;90%) were randomly assigned to receive aerosolized dornase alfa twice daily for 5 days or a placebo in addition to standard of care. The primary outcome was discharge from the hospital or an oxygen saturation &amp;gt;93% without respiratory support.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 76 patients were randomized. The study was stopped when the Omicron virus variant appeared. The clinical response rate did not differ between patients receiving the active substance and placebo. Secondary outcomes were similar across groups, such as mortality, a new episode of hypoxia, length of stay in the hospital, and adverse events. A subanalysis of patients older or younger than 65 years showed no differences in primary or secondary outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Aerosolized dornase alfa failed to improve hypoxia in hospitalized patients with acute COVID-19. The study was conducted during a time of heterogeneity in viral variants and vaccination status of participants. Whether dornase alfa affects the outcomes in other respiratory infections requires further study.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf246","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:49:28Z","timestamp":1745495368000},"source":"Crossref","is-referenced-by-count":12,"title":["Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19: A Randomized Controlled Trial"],"prefix":"10.1093","volume":"12","author":[{"given":"Per","family":"\u00c5kesson","sequence":"first","affiliation":[{"name":"Division of Infection Medicine, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7623-0342","authenticated-orcid":false,"given":"Lisa","family":"Mellhammar","sequence":"additional","affiliation":[{"name":"Division of Infection Medicine, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-5473","authenticated-orcid":false,"given":"Magnus","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Division of Infection Medicine, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2995-1312","authenticated-orcid":false,"given":"Malin","family":"Inghammar","sequence":"additional","affiliation":[{"name":"Division of Infection Medicine, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Jesperson","sequence":"additional","affiliation":[{"name":"Clinical Studies Sweden\u2013Forum South, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"M\u00e5nsson","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sk\u00e5ne University Hospital , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6296-2522","authenticated-orcid":false,"given":"Elin","family":"Economou Lundeberg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Central Hospital of Kristianstad , Kristianstad ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Walles","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Central Hospital of Kristianstad , Kristianstad ,","place":["Sweden"]},{"name":"Clinical Infection Medicine, Department of Translational Medicine, Lund University , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wallberg","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-4828","authenticated-orcid":false,"given":"Attila","family":"Frigyesi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-7239","authenticated-orcid":false,"given":"Adam","family":"Linder","sequence":"additional","affiliation":[{"name":"Division of Infection Medicine, Department of Clinical Sciences Lund, Lund University , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"2025052306582945100_ofaf246-B1","doi-asserted-by":"crossref","first-page":"00552-2021","DOI":"10.1183\/23120541.00552-2021","article-title":"Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study","volume":"8","author":"Reyes","year":"2022","journal-title":"ERJ Open Res"},{"key":"2025052306582945100_ofaf246-B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MCC.0000000000000911","article-title":"Pathophysiology of coronavirus-19 disease acute lung injury","volume":"28","author":"Camporota","year":"2022","journal-title":"Curr Opin Crit Care"},{"key":"2025052306582945100_ofaf246-B3","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.aam8897","article-title":"Host DNases prevent vascular occlusion by neutrophil extracellular traps","volume":"358","author":"Jim\u00e9nez-Alc\u00e1zar","year":"2017","journal-title":"Science"},{"key":"2025052306582945100_ofaf246-B4","doi-asserted-by":"crossref","first-page":"e32366","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS One"},{"key":"2025052306582945100_ofaf246-B5","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.chest.2019.08.2179","article-title":"Understanding the role of neutrophil extracellular traps in patients with severe pneumonia and ARDS","volume":"156","author":"Bendib","year":"2019","journal-title":"Chest"},{"key":"2025052306582945100_ofaf246-B6","doi-asserted-by":"crossref","first-page":"1701389","DOI":"10.1183\/13993003.01389-2017","article-title":"Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial","volume":"51","author":"Ebrahimi","year":"2018","journal-title":"Eur Respir J"},{"key":"2025052306582945100_ofaf246-B7","doi-asserted-by":"crossref","first-page":"e98178","DOI":"10.1172\/jci.insight.98178","article-title":"Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury","volume":"3","author":"Lefran\u00e7ais","year":"2018","journal-title":"JCI Insight"},{"key":"2025052306582945100_ofaf246-B8","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41467-019-09040-0","article-title":"Neutrophil extracellular traps in the central nervous system hinder bacterial clearance during pneumococcal meningitis","volume":"10","author":"Mohanty","year":"2019","journal-title":"Nat Commun"},{"key":"2025052306582945100_ofaf246-B9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm.4332","article-title":"Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation","volume":"23","author":"Toussaint","year":"2017","journal-title":"Nat Med"},{"key":"2025052306582945100_ofaf246-B10","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.mcpro.2021.100113","article-title":"Proteome profiling of recombinant DNase therapy in reducing NETs and aiding recovery in COVID-19 patients","volume":"20","author":"Fisher","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"2025052306582945100_ofaf246-B11","doi-asserted-by":"crossref","first-page":"e20200652","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med"},{"key":"2025052306582945100_ofaf246-B12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11239-020-02138-z","article-title":"Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum","volume":"50","author":"Barnes","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"2025052306582945100_ofaf246-B13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"2025052306582945100_ofaf246-B14","doi-asserted-by":"crossref","first-page":"e176640","DOI":"10.1172\/JCI176640","article-title":"Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality","volume":"134","author":"Gygi","year":"2024","journal-title":"J Clin Invest"},{"key":"2025052306582945100_ofaf246-B15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10020-020-00215-w","article-title":"Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series","volume":"26","author":"Weber","year":"2020","journal-title":"Mol Med"},{"key":"2025052306582945100_ofaf246-B16","doi-asserted-by":"crossref","first-page":"714833","DOI":"10.3389\/fimmu.2021.714833","article-title":"Non-randomized trial of dornase alfa for acute respiratory distress syndrome secondary to COVID-19","volume":"12","author":"Holliday","year":"2021","journal-title":"Front Immunol"},{"key":"2025052306582945100_ofaf246-B17","first-page":"8881115","article-title":"The use of dornase alfa in the management of COVID-19-associated adult respiratory distress syndrome","volume":"2021","author":"Toma","year":"2021","journal-title":"Crit Care Res Pract"},{"key":"2025052306582945100_ofaf246-B18","doi-asserted-by":"crossref","first-page":"109016","DOI":"10.1016\/j.clim.2022.109016","article-title":"Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure","volume":"238","author":"Gavriilidis","year":"2022","journal-title":"Clin Immunol"},{"key":"2025052306582945100_ofaf246-B19","doi-asserted-by":"crossref","first-page":"953195","DOI":"10.3389\/fimmu.2022.953195","article-title":"The role of neutrophil extracellular traps in acute lung injury","volume":"13","author":"Scozzi","year":"2022","journal-title":"Front Immunol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf246\/62997559\/ofaf246.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/5\/ofaf246\/62997559\/ofaf246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/5\/ofaf246\/62997559\/ofaf246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:58:39Z","timestamp":1747997919000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf246\/8119012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf246","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,24]]},"article-number":"ofaf246"}}